Both in Pharmaceuticals
Vera Therapeutics vs Zymeworks
Over the past year VERA returned +18.4% and ZYME returned +59.5%; their daily moves had a correlation of 0.35.
VERA +18.4% ZYME +59.5%Growth of $1, one year, split-adjusted
| Metric | VERA | ZYME |
|---|---|---|
| Price | $30.71 | $30.13 |
| Market cap | $2.21B | $2.17B |
| Today | +1.52% | +3.93% |
| 1 month | +3.0% | +15.0% |
| 6 months | −11.0% | +12.9% |
| Year to date | −39.4% | +14.4% |
| 1 year | +7.9% | +57.9% |
| Revenue growth (YoY) | — | −90.6% |
| Gross margin | — | 100.0% |
| Net margin | — | −980.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 58.3× |
| Net cash | $423.9M | $270.7M |
| Dividend yield | — | — |
| Volatility (60d) | 59.7% | 46.8% |
| Short % of float | 21.5% | 12.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).